摘要
目的对乳腺癌患者行自体乳房重建与植入物乳房重建术后患者报告结局(patient-reported outcome,PRO)进行评估。方法选取2020年1月至2021年6月在复旦大学附属肿瘤医院乳腺外科行乳房重建手术的患者,其中行自体乳房重建111例,行植入物乳房重建108例。应用中文版Breast-Q 2.0量表、乳腺癌特异性量表QLQ-BR23、EORTC生命质量测定量表QLQ-C30,通过问卷形式调查两组患者术后18个月的PRO。结果自体重建组中Ⅲ期乳腺癌高于植入物重建组(64.9%vs.44.4%,P<0.001),自体重建组在术前行新辅助治疗、术后放疗方面高于植入物重建(P<0.001),自体重建组术后行化疗、内分泌治疗低于植入物重建组(P<0.05)。基于BreastQ 2.0量表的研究显示自体重建组对乳房满意度高于植入物重建组(59.28±17.20 vs.54.94±14.48,P<0.05)。基于QLQ-BR23量表的研究显示在上肢症状领域自体重建组高于植入物重建组(20.02±20.80 vs.12.65±16.18,P<0.05)。基于QLQ-C30量表的研究显示患者在各功能领域及症状领域对比差异均无统计学意义。两组患者在术后社会回归人数与回归时间的差异无统计学意义。结论乳房重建可提高乳腺癌患者PRO,肿瘤学因素会影响乳腺癌重建方式的选择,自体乳房重建患者对乳房外形满意度更高,但是上肢症状(如肿胀、疼痛)较植入物重建组明显,这与自体重建患者行腋窝淋巴结清扫比例较高有关。两组患者在生活质量和社会回归方面差异不明显。
Objective To evaluate the patient-reported outcome(PRO)of patients with breast cancer who underwent autologous breast reconstruction and implant breast reconstruction.Methods Patients who underwent breast reconstruction in Shanghai Cancer Center,Fudan University from Jan 2020 to Jun 2021 were selected,including 111 patients who underwent autologous breast reconstruction and 108 patients who underwent implant breast reconstruction.Chinese version Breast-Q2.0 scale,breast cancer specificity scale QLQ-BR23 and EORTC quality of life scale QLQ-C30 were used to investigate the PRO of the two groups 18 months after operation.Results The rate of stageⅢbreast cancer in the self-weight construction group was higher than that in the implant reconstruction group(64.9%vs.44.4%,P<0.001).The preoperative neoadjuvant therapy and postoperative radiotherapy in the autologous reconstruction group were higher than those in the implant reconstruction group(P<0.001).Postoperative chemotherapy and endocrine therapy in the autologous reconstruction group were lower than those in the implant reconstruction group(P<0.001).The study based on Breast-Q scale showed that the breast satisfaction of autologous reconstruction group was higher than that of implant reconstruction(59.28±17.20 vs.54.94±14.48,P<0.05).The study based on QLQ-BR23 showed that the self-weight construction group was higher than the implant reconstruction group in the field of arm symptoms(20.02±20.80 vs.12.65±16.18,P<0.05).The study based on QLQ-C30 scale showed that there was no significant difference in all functional areas and symptom areas of patients.There was no significant difference in the number and time of social regression between the two groups.Conclusion Breast reconstruction can improve the PRO of breast cancer patients,and oncology factors will affect the choice of breast reconstruction.Patients with autologous breast reconstruction are more satisfied with breast appearance,but upper limb symptoms such as swelling and pain are more obvious than implant reconstruction,which is related to the higher proportion of axillary lymph node dissection in patients with autologous reconstruction.There is no significant difference in quality of life and social regression between the two groups.
作者
吴秋萍
吴炅
余科达
曹阿勇
黄晓燕
陈盛
王磊
管佳琴
WU Qiu-ping;WU Jiong;YU Ke-da;CAO A-yong;HUANG Xiao-yan;CHEN Sheng;WANG Lei;GUAN Jia-qin(Department of Nursing,Fudan University Shanghai Cancer Center,Shanghai 200032,China;Department of Breast Surgery,Fudan University Shanghai Cancer Center,Shanghai 200032,China;Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China)
出处
《复旦学报(医学版)》
CAS
CSCD
北大核心
2024年第1期81-88,127,共9页
Fudan University Journal of Medical Sciences
关键词
乳腺癌
乳房重建
患者报告结局(PRO)
满意度
生活质量
breast cancer
breast reconstruction
patient-reported outcome(PRO)
satisfaction
quality of life